top of page
pedader2.png

ABSTRACT SUBMISSIONS ARE NOW OPEN!

We are delighted to announce that Abstract submissions for e-Posters and Oral communications for ICOM2024 are now open.

To be considered for presentation at ICOM2024, it is essential to submit your abstract before 6th March 2024, 23:59 CEST. To ensure a fair and smooth review process, Abstracts submitted via e-mail will not be accepted. Therefore, it is essential to adhere to the provided guidelines and use the online submission system to ensure a successful Abstract submission.

Abstracts may be submitted for Oral Communication Session and e-Posters. The Scientific Programme Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.

Accepted authors will be notified of the decision by 31 March 2024.

 

Prof. Dr. Timucin Oral Travel Grant

The ICAM2024 offers a travel grant to help a couple of the abstract submitter with the cost of attending the Congress. Submit your Travel Grant application along with your abstract!

 

Rules for submission:

 

Please read the submission rules before submitting an abstract.

 

  • Abstracts must be submitted online via the website only.

  • Abstracts submitted by email will not be accepted.

  • Presentation Type: Abstracts may be submitted for oral communications or e-poster presentation.

  • The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.

  • Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
    Limitations:

  • The same person may submit up to 4 abstracts regardless of presenting author.

  • The same person may serve as presenting author on up to 4 abstracts.

  • Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by 31st March 2024 will be scheduled for presentation and included for publication.

  • Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress publications.

  • The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

  • Abstracts must be original and must not have been published or presented at any other prior meeting.

  • All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication

  • Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

  • Instructions for preparation of presentations will be made available on the congress website.

Guidelines for submission:

 

Before you begin, please prepare the following information:

 

  • Presenting author’s contact details:

    • Full first and family name(s)

      • Email address

      • Affiliation details: department, institution / hospital, city, state (if relevant), country

      • Phone number

    • Author and co-authors’ details

  • Preferred Presentation type: Oral Communications or E-Poster

  • Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.

  • Abstract text – For standardisation, the acceptable length of the abstract is limited to 3000 characters and 45 lines, with authors’ details, headers and tables included. This also includes non-visible characters such as spaces as well as punctuation.

  • Abstract topic– select the abstract topic per the list of topics.

  • Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format.

  • Abstracts should clearly state:

    • Background and aims

    • Methods

    • Results

    • Conclusions

for Case Report/Case Series:

  • Title of Case

  • Background

  • Case Presentation Summary

  • Learning Points/Discussion

  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.

  • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.

  • Submissions may not contain patient names, hospital ID numbers or other identifying information.

  • Please do not submit multiple copies of the same abstract.

Submission system information

 

  • Abstracts can be saved in “Draft” status to be re-edited and finalised until the submission deadline. Therefore, the submitter will be required to create a user account.

  • Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the congress.

  • Abstracts in “Final submission” status can be re-edited and modified until the submission deadline.

Abstract review

 

  • The abstracts will be reviewed by the Local Organising Committee and an experienced panel of reviewers. Following the information regarding acceptance, scheduling information will be sent to the Abstract Submitter.

Abstract submitters declaration

 

  • During abstract submission you will be asked to confirm that you agree to the following:

  • I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.

  • Submission of the abstract constitutes the consent of all authors to publication (e.g. Congress website, programs, other promotions, etc.)

  • The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to ICOM2024 and MYEVENT International Organizers of Congresses SA and its affiliates (together: the “Organizers“), nor the publication of any such Content by each of the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.

  • The Abstract Submitter grants each of the Organizers the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in each Organizer’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.

  • I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.

  • I understand that the presenting author must be a registered participant.

  • The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the above.

  • I understand that I must select a specific Theme, Topic and/or Sub-Topic for my abstract allocation. Although the Committee will work hard to honour this selection, this cannot be guaranteed. The Committee reserves the right to change the Theme, Topic or Sub-Topic under which the abstract was originally submitted.

  • I confirm to have received the consent of all authors for the processing of their contact details by MYEVENT and the Organizers.

 

Abstracts can be submitted in one of the following topics:

 

Authors are invited to submit abstracts, classified by topics.

 

  1. Addictive Disorders

  2. Anxiety Disorders and Somatoform Disorders

  3. Bipolar Disorders

  4. Child and Adolescent Psychiatry

  5. Classification of Mental Disorders

  6. Climate change

  7. Comorbidity/Dual Pathologies

  8. Consultation Liaison Psychiatry and Psychosomatics

  9. COVID-19 and related topics

  10. Cultural Psychiatry

  11. Depressive Disorders

  12. E-mental Health

  13. Eating Disorders

  14. Emergency Psychiatry

  15. Epidemiology and Social Psychiatry

  16. Ethics and Psychiatry

  17. Forensic Psychiatry

  18. Genetics and Molecular Neurobiology

  19. Guidelines/Guidance

  20. Intellectual Disability

  21. Mental Health Care

  22. Mental Health Policies

  23. Migration and Mental health of Immigrants

  24. Neuroimaging

  25. Neuroscience in Psychiatry

  26. Obsessive-Compulsive Disorder

  27. Old Age Psychiatry

  28. Oncology and Psychiatry

  29. Others

  30. Pain

  31. Personality and Personality Disorders

  32. Philosophy and Psychiatry

  33. Post-Traumatic Stress Disorder

  34. Precision Psychiatry

  35. Prevention of Mental Disorders

  36. Promotion of Mental Health

  37. Psychoneuroimmunology

  38. Psychopathology

  39. Psychopharmacology and Pharmacoeconomics

  40. Psychophysiology

  41. Psychosurgery and Stimulation Methods (ECT, TMS, VNS, DBS)

  42. Psychotherapy

  43. Quality Management

  44. Rehabilitation and Psychoeducation

  45. Research Methodology

  46. Schizophrenia and other Psychotic Disorders

  47. Sexual Medicine and Mental Health

  48. Sleep Disorders and Stress

  49. Suicidology and Suicide Prevention

  50. Training in Psychiatry

  51. Women, Gender and Mental Health

The correct topic must be selected to ensure correct scoring. The content of the abstract must be topic related.  The Committee reserves the right to change the topic under which the abstract was originally submitted.

bottom of page